Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
Michele W.L. Teng(The University of Queensland), Mark J. Smyth(Peter MacCallum Cancer Centre), Gurdyal S. Besra(University of Birmingham), Michael H. Kershaw(Peter MacCallum Cancer Centre), Jennifer A. Westwood(Peter MacCallum Cancer Centre), Phillip K. Darcy(Peter MacCallum Cancer Centre), Steven A. Porcelli(Albert Einstein College of Medicine), Janelle Sharkey(Peter MacCallum Cancer Centre), Moriya Tsuji(Aaron Diamond AIDS Research Center), Hideo Yagita∥(Juntendo University), Kazuyoshi Takeda(National Center of Neurology and Psychiatry), Richard W. Franck
Cited by 68
Related Papers
Immune surveillance of tumors
|Journal of Clinical Investigation|2007|1.4k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
|Nature Immunology|2012|832